Demant (WDH1) Stock Overview

Operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. More details

WDH1 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	3/6
Past Performance	2/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 67.7% below our estimate of its fair value

Earnings are forecast to grow 11.83% per year

Analysts in good agreement that stock price will rise by 30.2%

Risk Analysis

Has a high level of debt

WDH1 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Demant A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Demant
Historical stock prices
Current Share Price	DKK 28.30
52 Week High	DKK 32.26
52 Week Low	DKK 28.12
Beta	0.92
1 Month Change	-11.84%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	120.10%

Recent updates

Shareholder Returns

	WDH1	DE Medical Equipment	DE Market
7D	-7.3%	-5.9%	-4.2%
1Y	n/a	-15.7%	11.3%

Return vs Industry: Insufficient data to determine how WDH1 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how WDH1 performed against the German Market.

Price Volatility

Is WDH1's price volatile compared to industry and market?
WDH1 volatility
WDH1 Average Weekly Movement	4.0%
Medical Equipment Industry Average Movement	5.0%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	12.1%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: WDH1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine WDH1's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1904	22,057	Søren Nielsen	www.demant.com

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids and personalized hearing care products, as well as offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019.

Demant A/S Fundamentals Summary

How do Demant's earnings and revenue compare to its market cap?
WDH1 fundamental statistics
Market cap	€6.05b
Earnings (TTM)	€357.20m
Revenue (TTM)	€3.02b

16.9x

P/E Ratio

2.0x

P/S Ratio

Is WDH1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WDH1 income statement (TTM)
Revenue	DKK 22.59b
Cost of Revenue	DKK 5.46b
Gross Profit	DKK 17.13b
Other Expenses	DKK 14.46b
Earnings	DKK 2.67b

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	12.52
Gross Margin	75.83%
Net Profit Margin	11.81%
Debt/Equity Ratio	142.5%

How did WDH1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/19 10:48
End of Day Share Price	2025/11/19 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Demant A/S is covered by 40 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	ABG Sundal Collier
Edward Ridley-Day	Barclays
Hassan Al-Wakeel	Barclays

Demant A/SXTRA:WDH1 Stock Report